Literature DB >> 16502213

Clinical characteristics and long term prognosis in early onset multiple sclerosis.

Olivier Deryck1, Pierre Ketelaer, Bénédicte Dubois.   

Abstract

The clinical features, disease course and long term prognosis of early onset multiple sclerosis (EOMS) are variable. A preponderance of female sex, a high incidence of visual and brainstem symptoms at onset and a relapsing-remitting disease course with slower progression rate all have been considered relatively frequent in this subgroup of MS patients. Unfortunately, follow-up in previous studies has usually been limited to less than 10 years, precluding general statements on the long term evolution and prognosis in EOMS. In this retrospective study of EOMS with a substantially longer follow-up of 20.8 years, clinical characteristics, disease course and long term prognosis are described in 49 EOMS patients. In a representative subgroup of 28 patients disability was scored using Kurtzke's Functional System (FS) and Expanded Disability Status Scale (EDSS). The mean period of follow- up for these patients was 28.7 years. The present study confirms that several specific clinical characteristics can be identified in EOMS patients, such as a mainly relapsing-remitting disease onset and frequent presentation with brainstem- cerebellar dysfunction (28.6 %), pyramidal symptoms (18.4 %) and optic neuritis (14.3%). However, after a long period of follow-up the overall disease course and prognosis do not seem to differ from that in adult onset MS. By consequence a young age at onset in MS cannot be considered a favourable prognostic factor.

Entities:  

Mesh:

Year:  2006        PMID: 16502213     DOI: 10.1007/s00415-006-0095-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

Authors:  Christian Confavreux; Sandra Vukusic; Patrice Adeleine
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

2.  Early onset MS under the age of 16: clinical and paraclinical features.

Authors:  E Sindern; J Haas; E Stark; U Wurster
Journal:  Acta Neurol Scand       Date:  1992-09       Impact factor: 3.209

3.  Multiple sclerosis in childhood: report of 16 cases.

Authors:  D Selcen; B Anlar; Y Renda
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

4.  Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.

Authors:  M Trojano; C Avolio; C Manzari; A Calò; F De Robertis; G Serio; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

5.  Genetic factors in multiple sclerosis.

Authors:  G C Ebers
Journal:  Neurol Clin       Date:  1983-08       Impact factor: 3.806

6.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

7.  Multiple sclerosis in children under 6 years of age.

Authors:  M Ruggieri; A Polizzi; L Pavone; L M Grimaldi
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

8.  Course and prognosis in early-onset MS: comparison with adult-onset forms.

Authors:  I L Simone; D Carrara; C Tortorella; M Liguori; V Lepore; F Pellegrini; A Bellacosa; A Ceccarelli; I Pavone; P Livrea
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

Review 9.  Natural history of multiple sclerosis.

Authors:  B G Weinshenker
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

10.  Prediction of outcome in multiple sclerosis based on multivariate models.

Authors:  B Runmarker; C Andersson; A Odén; O Andersen
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

View more
  13 in total

1.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 2.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

Review 3.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

4.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence.

Authors:  Wiebke Stark; Peter Huppke; Jutta Gärtner
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

6.  Does early-onset multiple sclerosis differ from adult-onset form in Iranian people.

Authors:  Fereshteh Ashtari; Vahid Shaygannejad; Ziba Farajzadegan; Ali Amin
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852

7.  How does age at onset influence the outcome of autoimmune diseases?

Authors:  Manuel J Amador-Patarroyo; Alberto Rodriguez-Rodriguez; Gladis Montoya-Ortiz
Journal:  Autoimmune Dis       Date:  2011-12-13

8.  Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.

Authors:  Silvia Dell'Avvento; Maria Alessandra Sotgiu; Salvatorica Manca; Giovanni Sotgiu; Stefano Sotgiu
Journal:  Eur J Pediatr       Date:  2015-07-10       Impact factor: 3.183

9.  The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.

Authors:  Naeim Ehtesham; Maryam Zare Rafie; Meysam Mosallaei
Journal:  BMC Neurol       Date:  2021-06-28       Impact factor: 2.474

10.  Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Authors:  Mohsen Khademi; Ann M Dring; Jonathan D Gilthorpe; Anna Wuolikainen; Faiez Al Nimer; Robert A Harris; Magnus Andersson; Lou Brundin; Fredrik Piehl; Tomas Olsson; Anders Svenningsson
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.